A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

Multiple Sclerosis Journal

Volumn 21, Issue 3, 2015, Pages 282-293

  Marrie, Ruth Ann ^a   Reider, Nadia ^a   Cohen, Jeffrey ^b   Stuve, Olaf ^c   Sorensen, Per S ^d   Cutter, Gary ^e   Reingold, Stephen C ^f   Trojano, Maria ^g  

^a UNIVERSITY OF MANITOBA   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c University of Texas Southwestern   (United States)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Scientific and Clinical Review Associates LLC   (United States)

^g UNIVERSITY OF BARI   (Italy)

Author keywords

autoimmune disease; comorbidity; incidence; Multiple sclerosis; prevalence

Indexed keywords

ADRENAL CORTEX INSUFFICIENCY; ALOPECIA AREATA; ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BULLOUS PEMPHIGOID; CELIAC DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COMORBIDITY; DERMATOMYOSITIS; DIABETES MELLITUS; EMBASE; EYE DISEASE; GENETIC HETEROGENEITY; GUILLAIN BARRE SYNDROME; HEALTH CARE QUALITY; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INFORMATION PROCESSING; MEDLINE; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PATIENT RISK; PEMPHIGOID; PEMPHIGUS VULGARIS; POLYMYOSITIS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PSORIASIS; QUALITY OF LIFE; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THYROID DISEASE; UVEITIS; VITILIGO; WEB OF SCIENCE; WEGENER GRANULOMATOSIS; AGE DISTRIBUTION; AUTOIMMUNE HEMATOLOGIC DISORDER; AUTOIMMUNE THYROIDITIS; DATA EXTRACTION; ETHNIC DIFFERENCE; FACTUAL DATABASE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; INSULIN DEPENDENT DIABETES MELLITUS; QUALITY CONTROL; SEX DIFFERENCE; AUTOIMMUNE DISEASES;

AUTOIMMUNE DISEASES; COMORBIDITY; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 84924804522     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514564490     Document Type: Review

References (68)

1. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004 ; 3: 709-718
2. Cohen JA, Coles AJ, Arnold DL, et al. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: A randomised controlled phase 3 trial. Lancet. 2012 ; 380: 1819-1828
3. Barcellos LF, Kamdar BB, Ramsay PP, et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis A descriptive study. Lancet Neurol. 2006 ; 5: 924-931
4. Ghadirian P, Dadgostar B, Azani R, et al. A case-control study of the association between sociodemographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health. 2001 ; 92: 281-285
5. Seyfert S, Klapps P, Meisel C, et al. Multiple sclerosis and other immunologic diseases. Acta Neurol Scand. 1990 ; 81: 37-42
6. Zorzon M, Zivadinov R, Nasuelli D, et al. Risk factors of multiple sclerosis: A case-control study. Neurol Sci. 2003 ; 24: 242-247
7. Marrie R, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview.. 2015 ; 21 (3). 263-281
8. Neyeloff J, Fuchs S, Moreira L. Meta-analyses and Forest plots using a microsoft excel spreadsheet: Step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012 ; 5: 52
9. Cox DR. The continuity correction. Biometrika. 1970 ; 57: 217-219
10. Annunziata P, De Santi L, Di Rezze S, et al. Clinical features of Sjogren's syndrome in patients with multiple sclerosis. Acta Neurol Scand. 2011 ; 124: 109-114
11. Baker HWG, Balla JI, Burger HG, et al. Multiple sclerosis and autoimmune diseases. Aust N Z J Med. 1972 ; 2: 256-260
12. Basiri K, Etemadifar M, Maghzi AH, et al. Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran. Neurol India. 2009 ; 57: 638-640
13. Borhani Haghighi A, Ansari N, Mokhtari M, et al. Multiple sclerosis and gluten sensitivity. Clin Neurol Neurosurg. 2007 ; 109: 651-653
14. Buchanan RJ, Schiffer R, Stuifbergen A, et al. Demographic and disease characteristics of people with multiple sclerosis living in urban and rural areas. Int J MS Care. 2006 ; 8: 89-98
15. Cendrowski W. Multiple sclerosis and diseases of autoimmune or related origin. Mater Med Pol. 1989 ; 21: 327-329
16. De Keyser J. Autoimmunity in multiple sclerosis. Neurology. 1988 ; 38: 371-374
17. De Seze J, Canva-Delcambre V, Fajardy I, et al. Autoimmune hepatitis and multiple sclerosis: A coincidental association?. Mult Scler. 2005 ; 11: 691-693
18. De Seze J, Devos D, Castelnovo G, et al. The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis. Neurology. 2001 ; 57: 1359-1363
19. Deretzi G, Kountouras J, Koutlas E, et al. Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece. Mult Scler. 2010 ; 16: 1091-1101
20. Durelli L, Oggero A, Verdun E, et al. Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci. 2001 ; 193: 17-22
21. Eaton WW, Rose NR, Kalaydjian A, et al. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007 ; 29: 1-9
22. Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler. 2004 ; 10: 575-581
23. Fanouriakis A, Mastorodemos V, Pamfil C, et al. Coexistence of systemic lupus erythematosus and multiple sclerosis: Prevalence, clinical characteristics, and natural history. Semin Arthritis Rheum. 2014 ; 43: 751-758
24. Fleming ST, Blake Jr RL.. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol. 1994 ; 47: 1127-1132
25. Fromont A, Binquet C, Rollot F, et al. Comorbidities at multiple sclerosis diagnosis. J Neurol. 2013 ; 260: 2629-2637
26. Hanrahan PS, Russell AS, McLean DR. Ankylosing spondylitis and multiple sclerosis: An apparent association?. J Rheumatol. 1988 ; 15: 1512-1514
27. Henderson RD, Bain CJ, Pender MP. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J Clin Neurosci. 2000 ; 7: 434-437
28. Hoppenbrouwers IA, Cortes LM, Aulchenko YS, et al. Familial clustering of multiple sclerosis in a Dutch genetic isolate. Mult Scler. 2007 ; 13: 17-24
29. Horton M, Rudick RA, Hara-Cleaver C, et al. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010 ; 35: 83-90
30. Kang J-H, Chen Y-H, Lin H-C. Comorbidities amongst patients with multiple sclerosis: A population-based controlled study. Eur J Neurol. 2010 ; 17: 1215-1219
31. Karara AM, Macky TA, Sharawy MH. Pattern of uveitis in an Egyptian population with multiple sclerosis: A hospital-based study. Ophthalmic Res. 2013 ; 49: 25-29
32. Karni A, Abramsky O. Association of MS with thyroid disorders. Neurology. 1999 ; 53: 883-885
33. Langer-Gould A, Albers K, Van Den Eeden S, et al. Autoimmune diseases prior to the diagnosis of multiple sclerosis: A population-based case-control study. Mult Scler. 2010 ; 16: 855-861
34. Laroni A, Calabrese M, Perini P, et al. Multiple sclerosis and autoimmune diseases: Epidemiology and HLA-DR association in North-east Italy. J Neurol. 2006 ; 253: 636-639
35. Le Scanff J, Seve P, Renoux C, et al. Uveitis associated with multiple sclerosis. Mult Scler. 2008 ; 14: 415-417
36. Levinthal DJ, Rahman A, Nusrat S, et al. Adding to the burden: Gastrointestinal symptoms and syndromes in multiple sclerosis. Mult Scler Int. 2013 ; 2013: 319201
37. Marrie RA, Horwitz R, Cutter G, et al. Comorbidity, socioeconomic status, and multiple sclerosis. Mul Scler. 2008 ; 14: 1091-1098
38. Marrie RA, Horwitz RI, Cutter G, et al. Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases. Neuroepidemiology. 2011 ; 36: 85-90
39. Marrie RA, Yu BN, Leung S, et al. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology. 2013 ; 40: 85-92
40. Marrosu MG, Cocco E, Lai M, et al. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet. 2002 ; 359: 1461-1465
41. Marrosu MG, Motzo C, Murru R, et al. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet. 2004 ; 13: 2919-2924
42. Metz LM, Seland P, Fritzler M. An analysis of the frequency of Sjogren's syndrome in a population of multiple sclerosis patients. J Clin Lab Immunol. 1989 ; 30: 121-125
43. Midgard R, Gronning M, Riise T, et al. Multiple sclerosis and chronic inflammatory diseases. A case-control study. Acta Neurol Scand. 1996 ; 93: 322-328
44. Miró J, Peña-Sagredo JL, Berciano J, et al. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol. 1990 ; 27: 582-584
45. Monzani F, Caraccio N, Meucci G, et al. Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis. Eur J Endocrinol. 1999 ; 141: 325-331
46. Munteis E, Cano JF, Flores JA, et al. Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. Eur J Neurol. 2007 ; 14: 1048-1052
47. Niederwieser G, Buchinger W, Bonelli RM, et al. Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol. 2003 ; 250: 672-675
48. Nielsen N, Frisch M, Rostgaard K, et al. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: A nationwide cohort study in Denmark. Mult Scler. 2008 ; 14: 823-829
49. Noseworthy JH, Bass BH, Vandervoort MK, et al. The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol. 1989 ; 25: 95-98
50. Nuyen J, Schellevisa FG, Satarianob WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: A general practice-based controlled study. J Clin Epidemiol. 2006 ; 59: 1274-1284
51. Percy AK, Noberga FT, Okazaki H, et al. Multiple sclerosis in Rochester, Minn. A 60-year appraisal. Arch Neurol. 1971 ; 25: 105-111
52. Pitzalis M, Zavattari P, Murru R, et al. Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia. BMC Med Genet. 2008 ; 9: 3
53. Ramagopalan SV, Dyment DA, Valdar W, et al. The occurrence of autoimmune disease in Canadian families with multiple sclerosis. Lancet Neurol. 2007 ; 6: 604-610
54. Rodrigo L, Hernandez-Lahoz C, Fuentes D, et al. Prevalence of celiac disease in multiple sclerosis. BMC Neurol. 2011 ; 11: 31
55. Sadovnick A, Paty D, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease. N Engl J Med. 1989 ; 321: 762-763
56. Salter AR, Tyry T, Vollmer T, et al. 'Seeing' in NARCOMS: A look at vision-related quality of life in the NARCOMS registry. Mult Scler. 2013 ; 19: 953-960
57. Salvatore S, Finazzi S, Ghezzi A, et al. Multiple sclerosis and celiac disease: Is there an increased risk?. Mult Scler. 2004 ; 10: 711-712
58. Sandberg-Wollheim M, Axell T, Hansen BU, et al. Primary Sjogren's syndrome in patients with multiple sclerosis. Neurology. 1992 ; 42: 845-847
59. Sloka JS, Pryse-Phillips WEM, Stefanelli M, et al. Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort. J Autoimmune Dis. 2005 ; 2: 9
60. Solomon AJ, Hills W, Chen Z, et al. Autoantibodies and Sjogren's Syndrome in multiple sclerosis, a reappraisal. PLoS One. 2013 ; 8: e65385
61. Somer H, Muller K, Kinnunen E. Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings. J Neurol Sci. 1989 ; 89: 37-48
62. Tourbah A, Clapin A, Gout O, et al. Systemic autoimmune features and multiple sclerosis: A 5-year follow-up study. Arch Neurol. 1998 ; 55: 517-521
63. Tremlett HL, Evans J, Wiles CM, et al. Asthma and multiple sclerosis: An inverse association in a case-control general practice population. QJ Med. 2002 ; 95: 753-756
64. Wertman E, Zilber N, Abramsky O. An association between multiple sclerosis and type I diabetes mellitus. J Neurol. 1992 ; 239: 43-45
65. Wynn DR, Rodriguez M, O'Fallon WM, et al. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology. 1990 ; 40: 780-786
66. Marrie RA, Yu BN, Leung S, et al. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: A validation study using administrative data. Neuroepidemiology. 2012 ; 39: 135-142
67. Marrie RA, Horwitz RI, Cutter G, et al. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2011 ; 124: 135-141
68. Cossburn M, Pace AA, Jones J, et al. Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology. 2011 ; 77: 573-579